You have successfully logged out.

Hello !
Logout

Intermittent catheterisation

The impact of urinary tract infection

Urinary tract infection (UTI) is a common complication of intermittent urinary catheterisation that impacts a patients' overall health and quality of life.

Real-World Evidence

Act Safe: A Real-World data analysis of intermittent catheterisation

We conducted a Real-World evidence study to compare the effects of prelubricated (gel coated) and hydrophilic catheters on the incidence of symptoms suggestive of urinary tract infections (ssUTIs) amongst 5,296 people over a one-year study period.

Patients using prelubricated ISCs had significantly fewer ssUTIs per year (1.3 vs. 1.8). Significantly fewer patients using prelubricated catheters experienced an ssUTI (44.6% vs. 55.0%); our analysis shows that this is a difference of 20.9%.

Related Documents

  • Read the evidence summary

    Act Safe: "A real world data analysis of intermittent catheterisation"

    link

  • Read the full paper

    "A Real-world Data Analysis of Intermittent Catheterisation, Showing the Impact of Prelubricated Versus Hydrophilic Catheter Use on the Occurrence of Symptoms Suggestive of Urinary Tract Infections"

    link

  • NICE Guidance

    NICE guidance supports decisions on the choice of urinary catheters in guideline CG139 “Healthcare-associated infections: prevention and control in primary and community care.”

    link

actreen-mini-hilite.png

Actreen® Intermittent Catheters

Find out more

Actreen® Product Page

1. Flower, A., Bishop, F. L., & Lewith, G. (2014). How women manage recurrent urinary tract infections: an analysis of postings on a popular web forum. BMC family practice, 15(1), 1-8.

2. Ciani, O., Grassi, D., & Tarricone, R. (2013). An economic perspective on urinary tract infection: the “costs of resignation”. Clinical drug investigation, 33, 255-261.

3. Grigoryan, L., Mulgirigama, A., Powell, M., & Schmiemann, G. (2022). The emotional impact of urinary tract infections in women: A qualitative analysis. BMC Women's Health, 22(1), 182.

4. Mantle, S. (2015) Reducing HCAI- what the commissioner needs to know. - NHS england, NHS England. Available at: https://www.england.nhs.uk/wp-content/uploads/2015/04/10-amr-lon-reducing-hcai.pdf (Accessed: 10 July 2023).

5. NHS England (2018) Excellence in Continence Care. (Accessed: 10 July 2023)

6. Becker, L.C. et al. (2019) “Safety assessment of glycerin as used in cosmetics,” International Journal of Toxicology, 38(3_suppl). Available at: https://doi.org/10.1177/1091581819883820.

7. Veroniek S.M. Saegeman & al. Short- and long-term bacterial Source: The Soap and Detergent Association. Glycerin: an overview. 1990. inhibiting effect of high concentrations of glycerol used in the preservation of skin allografts. Burns 34 (2008) 205-211

8. Fluhr, J.W., Darlenski, R. and Surber, C. (2008) “Glycerol and the skin: Holistic approach to its origin and functions,” British Journal of Dermatology, 159(1), pp. 23–34. Available at: https://doi.org/10.1111/j.1365- 2133.2008.08643.x.